Form 4: Indivior Director Keith Humphreys Acquires RSUs

Indivior Pharmaceuticals, Inc. reports that Director Keith Humphreys was granted 6,518 Restricted Stock Units (RSUs) on May 13, 2026.

Summary

• Director Keith Humphreys received a grant of 6,518 Restricted Stock Units (RSUs) on May 13, 2026.
• Each RSU represents a contingent right to receive one share of Indivior Pharmaceuticals, Inc. common stock.
• These RSUs are set to vest on the day immediately preceding the date of the annual stockholders' meeting following the grant date.
• Vesting is contingent upon Mr. Humphreys' continued service to the company on the vesting date.
• Following this transaction, Mr. Humphreys beneficially owns 16,042 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity grant to a director rather than a significant financial event or strategic shift for the company.

Positives

• Director Keith Humphreys has been granted a significant number of Restricted Stock Units (6,518), indicating continued investment and alignment with the company's long-term performance.
• The grant of RSUs suggests management confidence in the company's future prospects, as their value is tied to the stock price.
• Mr. Humphreys' beneficial ownership increases to 16,042 shares, demonstrating a substantial personal stake in Indivior.

Risks

• The vesting of RSUs is contingent on continued service, meaning any departure from the company before the vesting date would result in forfeiture of these units.
• The value of the RSUs is subject to market fluctuations and the company's stock performance, posing a risk of value depreciation.

Future Outlook

The vesting schedule for the RSUs is tied to the annual meeting of stockholders following the grant date, indicating a forward-looking incentive structure for the director.

Industry Context

StockSavvy.ai notes that grants of Restricted Stock Units (RSUs) to directors are a common practice in the pharmaceutical industry as a means to incentivize long-term performance and align executive interests with shareholder value. This type of compensation is standard for retaining key leadership within the sector.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns director incentives with long-term shareholder value, potentially leading to better strategic decisions. The increase in beneficial ownership by a director can be seen as a positive signal.
• Employees: Standard compensation practices for directors can indirectly influence overall employee compensation strategies and morale.
• Management: The RSU grant reinforces the importance of continued service and performance for key leadership.

Next Steps

• The RSUs will vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant.
• Continued service by the Reporting Person to the Issuer on the vesting date is required for vesting.

Key Dates

Keywords

Indivior Pharmaceuticals, INDV, Form 4, Restricted Stock Units, RSUs, Director, Stock Grant, Beneficial Ownership, Insider Trading, SEC Filing